Researchers sought to identify frailty assessment tools and determine which are effective in patients undergoing hematopoietic stem cell transplantation.
A deepened understanding of long-term effects can help clinicians to better determine upfront therapy and monitoring strategies for pediatric patients with Hodgkin lymphoma.
An open-label, phase 2 trial was conducted at 10 centers in France and enrolled patients with sympotomatic, measurable newly diagnosed multiple myeloma.
This presentation discussed the key points of TEDDI-R protocol for managing the unique cluster of symptoms in patients with CNS lymphomas.
A retrospective analysis was conducted to determine the safety and efficacy of high-dose methotrexate in patients with high-risk DLBCL.